C21H23F3N6O3S2 — CID 135352176
(4S)-4-[(2S,4R)-2-(1-methylpyrazol-3-yl)-4-(trifluoromethyl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide (PubChem CID 135352176) has the molecular formula C21H23F3N6O3S2 and a molecular weight of 528.58 g/mol. Its IUPAC name is (4S)-4-[(2S,4R)-2-(1-methylpyrazol-3-yl)-4-(trifluoromethyl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide.
| Compound Name | (4S)-4-[(2S,4R)-2-(1-methylpyrazol-3-yl)-4-(trifluoromethyl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide |
|---|---|
| PubChem CID | 135352176 |
| Molecular Formula | C21H23F3N6O3S2 |
| Molecular Weight | 528.58 g/mol |
| Exact Mass | 528.12 |
| IUPAC Name | (4S)-4-[(2S,4R)-2-(1-methylpyrazol-3-yl)-4-(trifluoromethyl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide |
| SMILES | Cn1ccc([C@@H]2C[C@H](C(F)(F)F)CCN2[C@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)n1 |
| InChI | InChI=1S/C21H23F3N6O3S2/c1-29-7-5-16(27-29)18-10-13(21(22,23)24)4-8-30(18)17-6-9-33-19-11-14(2-3-15(17)19)35(31,32)28-20-25-12-26-34-20/h2-3,5,7,11-13,17-18H,4,6,8-10H2,1H3,(H,25,26,28)/t13-,17+,18+/m1/s1 |
| InChIKey | UEKOJRIGDCFSSL-BVGQSLNGSA-N |
| XLogP | 3.91 |
| TPSA | 102.24 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 528.58 |
| LogP ≤ 5 | 3.91 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |